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Summary and Key Points 
1. A variety of different malignancies fall into the category of “Head and 
Neck Cancers”. This chapter focuses on upper aerodigestive tract 
cancer. 
2. Tobacco and alcohol use and human papillomavirus infection are 
common causes of head and neck cancers. 
3. Most head and neck cancers are squamous cell carcinomas. 
4. Treatment of head and neck cancers commonly requires some 
combination of surgery, radiation, and chemotherapy. Close 
cooperation between otolaryngologists, radiation oncologists, and 
medical oncologists is mandatory for successful treatment of these 
cancers. 
5. Preservation of organ function in addition to cure of cancer, is an 
important goal of treatment. 
6. Any patient with persistent symptoms of sore throat, hoarseness, 
difficulty swallowing or an enlarged cervical lymph node should be 










A 65-year-old man complains of several months of progressive right sided 
throat pain, with development of a progressive right earache and 
progressive pain on swallowing over the last few days. He reports it hurts 
to swallow, even water, and has lost about 20 pounds over the last few 
months. He is an executive at a large company, denies use of tobacco or 
recreational drugs in any form, except occasional wine or beer. He runs 
marathons, but recently has become exhausted after running less than 3 
miles. 
On physical examination, he is six feet tall and weighs 180 pounds. A 2 
cm mobile firm, non-tender mass in the right upper neck just posterior to 
the angle of the mandible.  A 2 x 3 cm mass is visible along the right lateral 
oropharyngeal wall and base of tongue. His voice is normal (Figure 1a). 
CT of the neck was obtained for preliminary assessment (Figure 1a). 
PET/CT was then obtained to evaluate for local and distant metastatic 
disease which demonstrates the two masses and no evidence of further 
spread (Figure 1b). Biopsy of the oropharyngeal mass shows squamous 
cell carcinoma, which also stains with P16 immunostain, a surrogate 
marker for the presence of HPV in the tumor cells (Figure 1c, d, e, and f). 
HPV high risk molecular test performed later revealed the presence HPV 
16 DNA in this tumor. 
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Figure 1a. Photograph of right lateral oropharyngeal wall and base of tongue. 
Image courtesy of Duke University Division of Head and Neck Surgery and 
Communication Sciences. 
 
Figure 1b. CT of the neck shows a mass along the right lateral oropharyngeal wall 
in the region of the palatine tonsil (green arrow). Adjacent to the mass a pathologic 
appearing level 2A lymph node with necrosis (yellow arrow), located just posterior 
to the angle of the mandible. Image courtesy of the University of Massachusetts 
Medical School, Department of Radiology. 
 
Figure 1c. PET/CT of the neck was obtained to further confirm CT findings and 
evaluate for other potential sites of local and distant metastatic disease. The above 
image shows increased metabolic uptake in the right palatine tonsillar mass (green 
arrow) and in the pathologic right level 2A lymph node (yellow arrow). No other 
areas of abnormal uptake were seen in the remainder of the body. Of note, mild 
increased metabolic uptake in the left palatine tonsil is within normal physiologic 
range. Image courtesy of the University of Massachusetts Medical School, 
Department of Radiology. 
 
Figure 1d. (H&E stain, 40X magnification): Invasive SCC of the oropharynx 
showing normal squamous mucosa in the left upper corner of the picture 
(arrowheads). Nests of malignant cells (arrows) are seen infiltrating into the lamina 
propria with lymphoid tissue (stars). Image courtesy of the University of 
Massachusetts Medical School, Department of Pathology. 
 
Figure 1e. (H&E stain, 400X magnification): On higher magnification, a nest of 
malignant squamous cells (arrows) with hyperchromatic, enlarged nuclei and 
multiple mitotic figures. Note the presence of lymphoid stroma (stars) in the left 
upper corner of the picture. Image courtesy of the University of Massachusetts 
Medical School, Department of Pathology. 
 
Figure 1f. (P16 immunostain stain, 40X magnification): The malignant squamous 
cells (arrows) are positive for P16 immunostain, a surrogate marker for the 
presence of HPV in the tumor cells. Note that benign squamous mucosa 
(arrowheads) and lymphoid stroma (stars) are negative for P16 immunostain. 
Image courtesy of the University of Massachusetts Medical School, Department of 
Pathology. 
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Case 2 
A 50-year-old woman complains of oral pain; her dentist notes a mass 
along the undersurface of the tongue, extending onto the floor of mouth 
and refers her to an oral surgeon. She reports a 3 pack/day tobacco history 
since age 13, and drinks 2 shots of Bourbon and at least a six pack of 
beer/day. The oral surgeon palpates a mass in the floor of mouth fixed to 
the mandible (Figure 2a). Biopsies of the lesion shows grade 3 squamous 
cell carcinoma (Figure 2b & c). Palpation of the neck is unremarkable, and 
PET/CT confirms that the area of increased uptake is confined to the 
anterior tongue/floor of mouth lesion (Figure 2d & e). 
 
Figure 2a. Photograph of the lesion in floor of mouth. Image courtesy of Duke 
University Division of Head and Neck Surgery and Communication Sciences. 
 
Figure 2b. (H&E stain, 40X magnification): Invasive keratinizing squamous cell 
carcinoma of the tongue showing normal squamous mucosa in the left upper 
corner of the picture (arrowheads). Nests of malignant cells (arrows) are seen 
infiltrating into the submucosa and muscle fibers of the tongue (stars). Image 
courtesy of the University of Massachusetts Medical School, Department of 
Pathology. 
 
Figure 2c. (H&E stain, 400X magnification): Nests of squamous cell carcinoma 
cells (arrows) and muscle fibers (stars) Image courtesy of the University of 
Massachusetts Medical School, Department of Pathology. 
 
Figure 2d. CT of the neck demonstrates a soft tissue mass (green arrows) along 
the anterior floor of the mouth that erodes into the mandible. Image courtesy of the 
University of Massachusetts Medical School, Department of Radiology. 
 
Figure 2e. PET/CT demonstrates metabolic uptake in the tumor (green arrow). 
No pathologic lymph nodes were identified. Image courtesy of the University of 
Massachusetts Medical School, Department of Radiology. 
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Case 3 
A 40-year-old Chinese American man who reports he was born in a rural 
fishing village in southern China noted a painless lump in the right neck, 
nasal speech quality and sore throat. His physician noted that apparent 
tumor on the soft palate, ordered a contrasted enhanced CT of the neck, 
and referred him to an otolaryngologist. CT scan of the neck demonstrated 
a mass in the nasopharynx, invading the soft palate and protruding into 
the oropharynx (Figure 3a). Adenopathy of the right upper neck and 
submandibular region was also identified (Figure 3b). A fine needle 
aspirate of the submandibular node was performed, demonstrating 
malignant appearing squamous cells (Figure 3c). Biopsy of the lesion in 
the nasopharynx shows poorly differentiated squamous cell carcinoma 
(Figure 3d, e & f). 
 
Figure 3a. CT of the neck demonstrates a mass originating in the nasopharynx 
(green arrow) extending caudally to invade the soft palate (yellow arrow) and 
prolapse into the oropharynx (blue arrow). Image courtesy of the University of 
Massachusetts Medical School, Department of Radiology. 
 
Figure 3b. CT of the neck demonstrates pathologic lymph nodes in the right upper 
neck, level 2A (yellow arrow), and right submandibular region, level 1B (blue 
arrow). Image courtesy of the University of Massachusetts Medical School, 
Department of Radiology. 
 
Figure 3c. (H&E stain of cell block, 100X magnification): A cluster of malignant 
squamous cells (arrows) in a background of nuclear and keratin debris (stars) 
Image courtesy of the University of Massachusetts Medical School, Department of 
Pathology. 
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Figure 3d. (H&E stain, 40X magnification): Invasive poorly differentiated 
squamous cell carcinoma of the nasopharynx. Normal mucosa is seen in the left 
upper corner (arrowheads). Nests and cords of infiltrating tumor cells are present 
in the submucosa (arrows). Image courtesy of the University of Massachusetts 
Medical School, Department of Pathology. 
 
Figure 3e. (H&E stain, 400X magnification): On higher magnification, infiltrating 
malignant squamous cells (arrows) with hyperchromatic, enlarged nuclei are seen 
in the stroma. Image courtesy of the University of Massachusetts Medical School, 
Department of Pathology. 
 
Figure 3f. (Pancytokeratin immunostain, 40X magnification): Pancytokeratin 
immunostain highlights both benign epithelial cells (arrowheads, left upper corner) 
and malignant cells (arrows) in the submucosa. Image courtesy of the University 
of Massachusetts Medical School, Department of Pathology. 
Introduction 
Head and neck cancers include cancers of the skin, thyroid and upper 
aerodigestive tract including the lip, oral cavity, oropharynx, nasopharynx, 
larynx, paranasal sinuses, salivary glands, and carcinomas of unknown 
primary origin found in cervical lymph nodes. Oncologists recognize the 
tremendous disparity in tumors collected under the rubric of “head and 
neck cancer” and appreciate that a full understanding of the malignancies 
in this category requires consideration of the characteristics of individual 
tumors.  
This chapter focuses on cancers of the upper aerodigestive tract which 
are most often squamous cell carcinomas arising from the squamous 
epithelium that lines the tract. Overall though, these cancers are 
uncommon, accounting for only 3% of all malignancies in the United States 
(US). In 2018 64,700 new cases of oral cavity, oropharynx and larynx 
cancer will be diagnosed and 13,700 people are expected to die from this 
group of malignancies. (By comparison, 54,000 new cases of thyroid 
cancer and 234,000 new cases of lung cancer are expected.)1  
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Despite their heterogeneity, there are similarities in the therapeutic 
approaches to the different head and neck cancers. All modalities of anti-
cancer treatment– surgery, radiation, and chemotherapy– are frequently 
employed against these cancers. In addition to cure, organ preservation is 
a major concern of treatment because of the integral function of the 
structures involved with these tumors. Given the complex issues involved 
in treatment, head and neck cancers provide a perfect example of the 
need for a multi-disciplinary approach to cancer and the invaluable role 
that tumor boards play in planning treatment. 
This chapter is intended to provide an overview of head and neck cancers. 
Etiology, pathology, staging, and principles of treatment will be reviewed. 
Individual sites of cancer will be discussed only as examples to illustrate 
larger principles. 
Etiology 
In the US, head and neck cancers are strongly associated with tobacco 
use, including smoking, dipping, and chewing. Alcohol use is also strongly 
associated with these cancers, and the effect of tobacco and alcohol 
together is exponential, not simply additive, in increasing the risk for 
developing these cancers. Other organic substances that can come in 
contact with oral and nasal mucosal surfaces for long times (e.g., inhaled 
wood dust, the juice from betel nut chewing) are also known risk factors. 
All of these carcinogenic substances can bathe the epithelium throughout 
the mouth, nose, pharynx, and larynx and increase the risk of cancers 
developing at more than one site. This phenomenon is known as field 
cancerization. 
Viruses also play a role. Oncogenic strains of human papilloma virus 
(HPV) (notably HPV 16) can cause head and neck cancers especially in 
the tonsils and the base of tongue (both part of the oropharynx). Cancers 
caused by HPV tend to arise in patients about 10 years sooner than non-
HPV associated cancers and are less likely to arise in smokers and heavy 
drinkers. Interestingly, such cancers also tend to respond better to 
treatment and have a better prognosis than head and neck cancers not 
associated with HPV. The number of cases of HPV+ oropharyngeal 
cancers has been increasing rapidly in the United States, with the number 
of cases essentially doubling from1999 to 18,917 cases in 2015, when it 
was the most common HPV+ cancer in the United States. The rate of 
increase has been far greater in males than females; 82% of the HPV+ 
cancers occurred in men.2. Epstein-Barr virus is associated with 
nasopharyngeal carcinoma. 
Screening 
Because head and neck cancer is so uncommon compared to other 
malignancies, patients and health care providers do not often think of this 
as the cause of a sore throat or an enlarged lymph node. Any patient with 
persistent sore throat, hoarseness, dysphagia (difficulty swallowing), 
odynophagia (painful swallowing) or enlarged cervical lymph node lasting 
more than three months should be referred to an otolaryngologist for 
evaluation. It is appropriate for the primary care provider to prescribe 
antibiotics or antireflux medications as initial therapy because most 
patients will suffer from routine ailments. However, longer lasting 
symptoms, especially in adults over 40 or in patients with a history of 
tobacco and/or alcohol use, should trigger referral to an otolaryngologist-
head and neck surgeon for detailed physical exam. Of note, tobacco is 
also a strong risk factor for lung cancer, so anyone with head and neck 
squamous cell carcinoma (SCCA) in the setting of tobacco use should also 
undergo a chest X-ray as a basic screen for lung cancer. 
Pathology 
Most head and neck cancers arise from the epithelial lining, the most 
common histopathologic type being SCCA (Figure 4a and 4b).  
A significant exception to this is carcinomas of the salivary glands, which 
are frequently adenocarcinomas (Figure 5a and 5b). Minor and major 
salivary glands are scattered throughout the upper aerodigestive tract so 
the tumors arising in salivary glands must remain in the differential 
diagnosis along with less common malignancies such as mucosal 
melanomas (Figure 6a and 6b) while evaluating patients with head and 
neck cancers. 
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Figure 4a. (H&E stain, 20X magnification) A representative picture from a case 
with squamous cell carcinoma of gingiva. Normal squamous mucosa is shown in 
the upper portion of the picture (arrows) and infiltrating malignant squamous cells 
below it (arrow heads). Image courtesy of the University of Massachusetts Medical 
School, Department of Pathology. 
 
Figure 4b. (H&E stain, 400X magnification) Sheets of infiltrating malignant 
squamous (arrows) cells with hyperchromatic and enlarged nuclei. Squamous cell 
carcinoma cells are focally trying to form keratin pearls (arrow heads). Image 
courtesy of the University of Massachusetts Medical School, Department of 
Pathology. 
 
Figure 5a. (H&E stain, 20X magnification) A representative picture from a case 
with acinic cell adenocarcinoma of salivary gland. Normal salivary gland is on the 
left (delineated by arrows) and the tumor is on the right (delineated by 
arrowheads). Image courtesy of the University of Massachusetts Medical School, 
Department of Pathology. 
 
Figure 5b. (H&E stain, 200X magnification) Sheets of malignant tumor cells with 
purple granular cytoplasm (zymogen granules) consistent with salivary gland 
serous acini differentiation. Image courtesy of the University of Massachusetts 
Medical School, Department of Pathology. 
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Figure 6a. (H&E stain, 20X magnification) A representative picture from a case 
with malignant melanoma of the palate. Normal squamous mucosa is shown in the 
right side of the picture (arrows) and infiltrating malignant melanoma cells in the 
left side (arrow heads). Image courtesy of the University of Massachusetts Medical 
School, Department of Pathology. 
 
Figure 6b. (H&E stain, 400X magnification). Sheets of infiltrating malignant 
melanoma (arrowheads) cells with hyperchromatic and enlarged nuclei and 
prominent nucleoli. Melanin pigment (arrows) is seen in the cytoplasm of some 
tumor cells. Image courtesy of the University of Massachusetts Medical School, 
Department of Pathology. 
Prognostic Factors 
The stage of the cancer, the response to the initial treatment course and 
Human Immunodeficiency Virus (HIV) status are important prognostic 
factors. Advanced tumors, recurrent cancer and cancer in the setting of 
HIV positive serology all portend a worse prognosis. SCCA arising from 
HPV has a better prognosis than non-HPV SCCA. Immunosuppression 
after organ transplant is a very important prognostic factor for skin 
cancers. 
Staging 
Staging of head and neck cancers differs from many other solid tumors 
because of the propensity for these tumors to spread locally. Distant 
spread (e.g., to bones, lungs, liver, etc.) is less common than direct 
extension of tumors into adjacent structures. Similarly, death from these 
cancers is frequently due to complications from extensive tumor burden in 
the head, face, or neck. These complications include aspiration and 
malnutrition from an inability to swallow, and exsanguination from tumor 
erosion into an artery. 
Since the extent of local disease is critical to staging, a good 
otolaryngology exam is mandatory, and is supplemented with diagnostic 
imaging. Endoscopy can provide direct visualization of the superficial 
mucosal detail of the tumor (Figure 7) while diagnostic imaging provides 
assessment of the depth of tumor, involvement of adjacent structures, and 
metastatic disease (Figure 8). Modalities typically used for head and neck 
imaging include computed tomography (CT) (Figure 9a, b & d-f), magnetic 
resonance imaging (MRI) (Figure 10), and positron emission tomography 
with computed tomography (PET/CT) (Figures 9c & 11). A thorough 
clinical exam and appropriate imaging are important in the diagnosis and 
staging of head and neck cancers. 
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Figure 7. Endoscopic image of a T1 Squamous cell carcinoma of the True Vocal 
Cord. A cancer in this location is highly unlikely to metastasize, even to regional 
nodes, because of the lack of lymphatic channels in the true vocal cords. Image 
courtesy of Duke University, Department of Otolaryngology. 
 
Figure 8. Axial (a) and sagittal (b) CT of the neck with contrast demonstrate a 
vocal cord polyp (blue arrow) protruding into the larynx from the right true vocal 
cord. The patient had a long history of smoking and alcohol use with worsening 
hoarseness of the voice. The patient was hospitalized in respiratory distress. The 
polyp caused a ball valve effect making expiration progressively more difficult. 
Pathology revealed a squamous cell carcinoma. After excision, breathing returned 
to normal and hoarseness significantly improved. Image courtesy of University of 
Massachusetts Medical School, Department of Radiology. 
 
 
Figure 9a. Axial (a & b) and sagittal (c) CT of the neck with contrast shows a lesion 
in the oral cavity along the ventral surface of the tongue. While clinically obvious 
by direct visualization of the mucosa, a combination of clinical and radiologic 
imaging is often necessary for staging. Note in Figure 9a, the oral cavity is 
obscured by metallic streak artifacts from dental fillings and implants. Without the 
clinical information of an oral cavity lesion, the artifacts would have made detection 
of this squamous cell carcinoma more challenging and potentially missed by 
imaging alone. Figure 9b (caudal to Figure (a) and 9c demarcate the margins of 
this pathology proven squamous cell carcinoma (yellow arrowheads). Image 
courtesy of University of Massachusetts Medical School. Department of Radiology. 
 
Figure 9b. Axial (a) and sagittal (b) CT of the neck with contrast show a subtle 
ulcerative lesion along the right ventral surface of the tongue (yellow arrowheads). 
While the superficial mucosal detail of this ulcerative lesion is better identified by 
direct visualization, imaging is helpful to evaluate the depth of local invasion of the 
soft tissues as well as possible bone and lymph node involvement. Image courtesy 
of University of Massachusetts Medical School, Department of Radiology. 
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Figure 9c. PET/CT images from the above patient shows hypermetabolic activity 
in the region ulceration (yellow arrowhead). A. CT is unremarkable. b. PET image 
of same level: Unexpectedly, increased metabolic activity was also seen along the 
buccal surface of the mandible (blue arrowhead). This lesion had extended 
submucosally across the gingival surface and was not clinically evident. Image 
courtesy of University of Massachusetts Medical School. Department of Radiology. 
 
Figure 9d. Sagittal CT of the neck in Figure 9da shows a transglottic mass 
involving the supraglottic, glottic, and subglottic larynx (yellow arrowhead). A total 
laryngectomy was performed Figure 9db. Tracheostomy and nasogastric tubes 
have been placed. Image courtesy of the University of Massachusetts Medical 
School. Department of Radiology. 
 
Figure 9e. Axial CT of the neck with contrast shows an ulcerative lesion at the left 
tongue base (yellow arrowheads) with a pathologic necrotic level 2A lymph node 
(arrow). Image courtesy of the University of Massachusetts Medical School, 
Department of Radiology. 
 
Figure 9f. Pathologically enlarged lymph nodes with central necrosis (arrows) are 
demonstrated on this contrast enhanced CT of the neck. In a young adult without 
a history of smoking or alcohol abuse, there is increased likelihood that this is HPV 
related which tends to have a better prognosis. Image courtesy of the University 
of Massachusetts Medical School, Department of Radiology. 
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Figure 10a. CT of the temporal bones in a patient with chronic left ear pain. a: 
demonstrates fluid in the left middle ear cavity and mastoid air cells (red arrow). b: 
A mass was identified at the skull base along the left nasopharynx and 
retropharyngeal space (yellow arrowheads) obstructing the Eustachian tube. 
Image courtesy of the University of Massachusetts Medical School, Department of 
Radiology. 
 
Figure 10b. MRI of the above patient better delineates the margins of this mass. 
Figure 10ba is a T1 image showing the soft tissue mass infiltrating and displacing 
the normal fat around the left nasopharyngeal mucosa and retropharyngeal space 
(yellow arrowheads). Figure 10bb is a T1 fat saturated post contrast image shows 
corresponding abnormal enhancement of this region and skull base of this 
infiltrative lesion. Image courtesy of the University of Massachusetts Medical 
School. Department of Radiology. 
 
Figure 11. CT/PET PET is fused into CT image set and color enhanced on 
radiation oncology treatment planning system. Cancer of lateral wall of oropharynx: 
a: Lower extent of disease, note uninvolved epiglottis (arrow) b: Middle of disease, 
note base of tongue (arrow) with anterior tonsillar pillar/soft palate posterior to 
tongue c: Superior extent of disease, blue arrow points at tonsil. Green arrows 
point at inflamed parotid gland on right and intraparotid nodes on left. Image 
courtesy of the University of Massachusetts Medical School, Department of 
Radiation Oncology. 
The current positron emitter used in PET, 18F-glucose, is readily taken up 
by many cancers of the head and neck, but also by inflammatory cells and 
the normal brain. Hence, it may be difficult at times to distinguish a lymph 
node involved with tumor from an inflamed lymph node on PET3. (Figure 
11c). In this case a needle biopsy such as a fine needle aspiration (FNA) 
of the lymph node can be very helpful (Figure 12). 
 
Figure 12. Aspiration biopsy (cytology, left image 100X, right image 400X 
magnification) of squamous cell carcinoma. Image courtesy of University of 
Massachusetts, Department of Pathology. 
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As with any cancer patient, a distant metastatic workup must also be 
performed.  Head and neck cancer, both SCCA and other histologic types, 
are most likely to spread first to regional lymph nodes, less commonly to 
the lungs and then to the liver and other sites. 
The staging system currently used for many head and neck cancers is 
located here. Note that Stage IV disease can occur in the absence of 
distant spread of tumor. Either bulky cervical lymphadenopathy or tumor 
invasion into structures adjacent to the primary organ constitutes Stage IV 
disease, as does distant metastatic disease. 
Principles of Treatment 
Most head and neck cancers that have not spread beyond cervical lymph 
nodes are potentially cured with current treatments. However, once these 
cancers have spread into distant sites, such as lungs, bone, or liver, they 
are incurable and treatment is largely palliative. Current curative 
treatments will employ some combination of regional therapy using 
surgery and/or radiation, frequently with chemotherapy that is either given 
before radiation treatment (“induction” chemotherapy) or concurrent with 
radiation therapy One of the main principles of treatment is to minimize 
treatment modalities in an attempt to mitigate negative effects on function 
(i.e. utilizing surgical or non-surgical therapies alone to effect cure). 
In addition to the goal of cure, another major treatment goal is preserving 
the functions of the structures involved by these tumors. Organ 
preservation protocols involving radiation +/- chemotherapy allow for 
anatomic preservation of structures within the upper aerodigestive tract. 
The function of these organs is rarely completely normal after radiation, 
but the majority of patients are able to breathe and swallow, keep their 
larynx and avoid permanent tracheostomy and gastrostomy tubes. 
Currently, radiation or surgery appear to do equally well for most small 
(Stage I or II) head and neck tumors. In general, more extensive tumors 
are best treated with induction chemotherapy followed by concurrent 
chemotherapy and radiation with surgery reserved for tumors that do not 
achieve complete remission. An exception to this general rule are cancers 
of the oral cavity which have a better survival rate if surgery is performed 
first followed by radiation +/- chemotherapy.  
Surgery 
The goal of surgery is to completely remove all of the cancer while 
preserving as much uninvolved tissue as possible (Figure 13). 
 
Figure 13. Gross image of total laryngectomy specimen, showing a large cancer 
of the larynx originating from the right side. Image courtesy of Duke University, 
Department of Otolaryngology. 
Due to the confined anatomic region of the head and neck, margins are 
much closer than in other areas of the body and sacrifice of adjoining 
tissue can have a significant impact on patient function. In addition to 
surgical removal of the primary cancer, patients with higher stage tumors 
also require neck dissection to remove the lymph node beds that drain the 
primary site. In these cases, neck dissections are both therapeutic (by 
removing the lymph nodes) and staging (by establishing the extent of 
disease). However, recent data suggests that complete response (CR) on 
post treatment PET/CT scan of initially node positive head and neck 
cancer predicts excellent long-term disease free survival, and that neck 
dissection can be safely avoided in patients achieving CR.4. 
Immediate reconstruction after cancer resection is of prime importance to 
allow patients to return to swallowing and speaking. Local, regional and 
distant free tissue flaps are essential components of the surgical care of 
many of these patients. Patients may require temporary tracheostomy and 
nasogastric feeding tubes as they heal from surgery, and fistulas caused 
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by a breakdown in the pharynx with leakage of saliva into the neck are of 
special concern because they prohibit oral intake and delay healing. 
Surgery can be used as solitary treatment of early stage cancer. In more 
advanced cases or if pathological evaluation reveals signs of more 
aggressive cancer (such as perineural or lymphovascular invasion), 
surgery is often followed by radiation therapy with or without 
chemotherapy to increase the chances for cure. Surgical salvage is used 
when patients have undergone nonsurgical treatment for their cancers but 
suffer from persistent or recurrent disease. Surgery in the post-radiation 
setting is associated with increased wound healing problems but does 
provide an effective cure in many cases. 
Radiation Therapy 
Radiation therapy (RT) may be used as a solitary treatment modality for 
early stage tumors or as first line therapy in combination with 
chemotherapy for more advanced disease. RT is also given after surgery 
when the primary tumor is large or has aggressive features or there are 
multiple lymph nodes involved with cancer. Radiation has the great 
advantage of organ preservation but does have some significant side 
effects like loss of salivary function, possible permanent lymphedema, 
possible radionecrosis of the mandible and permanent alteration in 
swallowing from scar tissue that may develop in the pharynx and neck 
musculature. Intensity Modulated Radiation Therapy (IMRT) allows for 
targeted delivery of radiation to the tumor site with smaller doses to the 
surrounding structures. This allows for greater preservation of salivary and 
swallowing functions that are essential to maintaining a good quality of life 
for head and neck cancer patients. 
In general, RT lasts for 5-7 weeks depending on the stage of the cancer 
and whether the radiation is being given as first line therapy or in a 
postsurgical setting. Patients usually do not have many side effects the 
first four weeks of therapy. Fatigue, mucositis and other side effects may 
present toward the end of treatment and continue for several weeks after 
completion of RT. 
RT for T1 true vocal cord cancer involves a tiny field encompassing only 
the larynx; for a T2 laryngeal cancer, only first echelon lymph nodes are 
treated. (Figure 14a & b). While patients will have a sore throat during 
treatment, these treatments are usually very well tolerated. Late effects 
are largely restricted to voice changes, although professional singers have 
sometimes been able to return to professional singing after RT to the 
larynx. 
 
Figure 14a. True vocal cord treatment volume. Yellow line illustrates 100% dose 
line, or edge of treatment field for treatment of T1 TVC cancer. Image courtesy of 
the University of Massachusetts Medical School, Department of Radiation 
Oncology. 
 
Figure 14b. True vocal cord nodal treatment volume for a T2 N0 TVC cancer. 
Yellow line again illustrates edge of treatment field. Dose for treatment of N0 nodal 
volume is less than that required for gross disease, so the TVC volume shown in 
Figure 11a is treated to higher dose. Image courtesy of the University of 
Massachusetts Medical School, Department of Radiation Oncology. 
Treatment of large volumes (Figure 15) of the upper aerodigestive tract is 
much more difficult, with dry mouth, and loss of taste often interfering with 
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hydration and nutrition. Some patients may require placement of a 
temporary feeding tube if they are unable to maintain oral intake and 
occasionally some patients require a tracheostomy tube because of airway 
edema. For those patients treated with radiation alone or in combination 
with chemotherapy, maintaining oral intake (even if a temporary feeding 
tube is necessary) is essential to preserving long-term swallowing 
function. Avoiding treatment breaks is essential for optimizing chance of 
cure, and adequate nutrition is a critical piece of the supportive care 
required to get patients through RT treatment. 
 
Figure 15. Simple AP treatment field for palliation of massive tumor in the base of 
tongue. The entire upper aerodigestive tract is in the treatment volume. Image 
courtesy of the University of Massachusetts Medical School, Department of 
Radiation Oncology. 
The most important late effect for patients’ quality of life is severe dry 
mouth, which also can lead to issues with cavities and loss of teeth. For 
this reason, evaluation by a dentist or oral surgeon expert in the 
management of RT patients should occur as early in initial work-up as 
possible. The degree of dryness depends on the volume of remaining 
functional salivary gland tissue. IMRT permits sparing of, for example, the 
contralateral parotid gland (when possible), which significantly decreases 
severity of dry mouth (Figure 16). Except for early laryngeal cancer without 
lymph node metastases, IMRT has become standard of care for head and 
neck cancer treatment. 
 
Figure 16a. IMRT treatment plan CT slice for Stage III, T3N0 squamous cell 
carcinoma of base of tongue. Yellow line is 7000 cGy, the prescription dose for the 
primary tumor (red). The radiation oncologist felt tumor arose on right, therefore 
the right nodal volume was at greater risk, so has elected to relatively spare the 
left parotid and adjacent lymph nodes. Image courtesy of the University of 
Massachusetts Medical School, Department of Radiation Oncology. 
 
Figure 16b. Treatment plan CT slice superior to the slice in 13a, showing relative 
sparing of left parotid (parotids are pink volumes adjacent to mandible). Image 
courtesy of the University of Massachusetts Medical School, Department of 
Radiation Oncology. 
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Figure 16c. Dose Volume Histogram (DVH) demonstrating relative sparing of left 
parotid (thin arrow) compared to left (thick arrow). Y axis is % of volume of the 
particular organ, and x axis is dose in cGy. Parotid tissue tolerance for continued 
salivary function is 1500cGy. Arrows both point at 1500 cGy and show that greater 
than 90% of right parotid will receive in excess of this dose, while only 30% of the 
left one will. Image courtesy of the University of Massachusetts Medical School. 
Department of Radiation Oncology. 
Chemotherapy 
Chemotherapy alone is not a mainstay for treatment of head and neck 
cancers but may be used in a solitary fashion for palliation of disease. The 
main role of chemotherapy is to sensitize the tissue to increase the 
effectiveness of radiation. Thus, it may be used as an initial treatment prior 
to radiation in the form of induction chemotherapy or simultaneous with 
radiation in the form of concurrent chemotherapy. Platinum-based drugs 
are most commonly used as sensitizing agents, but small-molecule 
inhibitors and monoclonal antibody agents also comprise an important role 
in certain head and neck cancer treatment protocols.  
Outcome 
Outcome is reported for each disease site separately, by stage. For 
example, 5-year relative survival rates for supraglottic cancer were 59.0% 
for localized disease, 53% for regional disease (positive lymph nodes, and 
34% for distant disease (distant metastases) in 1995-96. True vocal cord 
cancer 5-year survival was 90% for Stage I disease, 74% for Stage II, 56% 
for Stage III disease, and 44% for Stage IV disease in the same period.5. 
And most of the T1 and T2 true vocal cord patients retained their larynx. 
Close follow-up by physicians trained in direct or at least indirect 
visualization of the larynx and physical examination of the head and neck 
is very important, as regional recurrences may be salvaged for long term 
disease-free survival if the recurrences are found early. But locally 
advanced recurrences are almost always treated with palliative intent 
(Figure 17). 
 
Figure 17. Axial (a) and sagittal (b) CT of the neck with contrast images shows 
pathology proven squamous cell carcinoma recurrence (yellow arrowheads) which 
occurred outside of the irradiated area. Long term surveillance of patients with 
head and neck cancers is advised. This patient had a transoral robotic supraglottic 
laryngectomy and adjuvant radiation. One year later he developed a fungating 
mass that obliterated his tracheostomy tract, projecting out through the skin and 
posteriorly into the trachea. Image courtesy of the University of Massachusetts 
Medical School, Department of Radiology. 
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Conclusion 
Cancers of the upper aerodigestive tract are most often SCC. Tobacco 
and alcohol are the leading causes; recently an epidemic of HPV cancers, 
particularly of the oropharynx has developed. It is hoped that HPV 
vaccination may decrease the incidence of this disease in the future. 
Management of these cancers requires a full multidisciplinary team: 
otolaryngologist, radiation oncologist, medical oncologist, diagnostic 
radiologist, qualified dentist/oral surgeon, nutritionist and social worker at 
a minimum. While these cancers, especially the HPV+ ones, appear in 
patients from all walks of life and economic statuses, the importance of 
tobacco and especially alcohol in the lives of many patients means that 
their life situations are often very complicated, requiring considerable 
social support during treatment. 
The fact that these cancers are less likely to spread beyond the neck 
means that even very advanced malignancies are often curable, so late 
effects are an important consideration in treatment decisions. And many 
of these patients will live to experience second, third and fourth cancers of 
the aerodigestive tract. 
Thought Questions 
1. A 48-year-old man whose wife of 20 years recently underwent 
treatment for cervical cancer presents with left-sided sore throat for 
two months and an enlarged left neck lymph node noticed 
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2. A 65-year-old woman receiving concurrent chemo/radiation therapy 
for an oropharyngeal SCCA is having significant trouble with 




















3. A patient has Stage II oropharyngeal cancer with known indications 
for radiation therapy. The patient desires surgery first followed by 
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Glossary 
Aerodigestive tract- The oral and nasal cavities and throat, and some 
people include the trachea and esophagus, through which air, food and 
liquids pass 
Exsanguination- Severe blood loss, sufficient to cause death 
Field cancerization– Atypia ranging from mild abnormality to invasive 
cancer that affects a wide area of an anatomic region usually involving 
multiple sites to various degrees 
Transglottic- A cancer which involves both false cord and true vocal cord, 
extending through the laryngeal ventricle. 
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